首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1707977

灌裝製造市場規模、佔有率、成長分析（按產品類型、按藥品類型、按最終用戶、按地區）- 產業預測 2025-2032

Fill Finish Manufacturing Market Size, Share, and Growth Analysis, By Product Type (Consumables, Equipment), By Drug Type (Biologics, Small Molecules), By End-user, By Region - Industry Forecast 2025-2032

出版日期: 2025年04月08日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023 年灌裝製造市場規模價值 167 億美元，預計將從 2024 年的 182.7 億美元成長到 2032 年的 374.9 億美元，預測期內（2025-2032 年）的複合年成長率為 9.4%。

截至 2023 年 10 月，全球對抗 COVID-19 的鬥爭正在激發製藥和生物技術領域的活力，重點是疫苗開發和藥物輸送系統。目前，該產業有超過 155 種化合物和約 115 種候選疫苗處於研發階段，並有望顯著成長。對羥氯喹等成熟療法的需求激增，凸顯了對有效的 COVID-19 管理解決方案的迫切需求，並為製造商創造了有利可圖的機會，特別是在面臨供不應求的富裕市場。目前，最終產品製造中的先進技術正在滿足日益成長的消費者需求並推動生物製藥的發展。此外，用於腸外給藥的預填充式注射器的日益普及預計將增強市場動態，並加強未來幾年該行業的強勁發展軌跡。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司詳情
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

Thermo Fisher Scientific Inc.（USA）
Cytiva（USA）
Fujifilm Holdings Corporation（Japan）
OPTIMA Packaging Group GmbH（Germany）
Curia Global, Inc.（USA）
Baxter International Inc.（USA）
Becton, Dickinson and Company（USA）
Aenova Group（Germany）
SGD Pharma（France）
Groninger & Co. GmbH（Germany）
West Pharmaceutical Services, Inc.（USA）
Stevanato Group（Italy）
Syntegon Technology GmbH（Germany）
Robert Bosch GmbH（Germany）
Gerresheimer AG（Germany）
Schott AG（Germany）
IMA Group（Italy）
AptarGroup, Inc.（USA）
Nipro Corporation（Japan）
Vetter Pharma-Fertigung GmbH & Co. KG（Germany）

結論和建議

簡介目錄

Product Code: SQMIG35H2229

Fill Finish Manufacturing Market size was valued at USD 16.7 billion in 2023 and is poised to grow from USD 18.27 billion in 2024 to USD 37.49 billion by 2032, growing at a CAGR of 9.4% during the forecast period (2025-2032).

As of October 2023, the global fight against COVID-19 continues to energize the pharmaceutical and biotechnology sectors, particularly in vaccine development and drug delivery systems. With over 155 drug compounds and approximately 115 vaccine candidates in research and development, the industry is poised for notable growth. A surge in demand for established treatments like hydroxychloroquine underscores the urgent need for effective COVID-19 management solutions, creating lucrative opportunities for manufacturers, especially in affluent markets facing supply shortages. Advanced technologies in fall-finish manufacturing now respond to escalating consumer needs, propelling biopharmaceutical growth. Additionally, the rising popularity of prefilled syringes for parenteral dosing is predicted to enhance market dynamics, reinforcing the industry's robust trajectory in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Fill Finish Manufacturing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Fill Finish Manufacturing Market Segments Analysis

Global Fill Finish Manufacturing Market is segmented by Product Type, Drug Type, End-user and region. Based on Product Type, the market is segmented into Consumables and Equipment. Based on Drug Type, the market is segmented into Biologics, Small Molecules, Vaccines and Other Injectables. Based on End-user, the market is segmented into Pharmaceutical Companies, Biopharmaceutical Companies and Contract Manufacturing Organizations (CMOs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Fill Finish Manufacturing Market

The Fill Finish Manufacturing market is primarily driven by the increasing demand for biologics, including vaccines, monoclonal antibodies, and gene therapies. As the complexity of these biologics rises, ensuring their sterility throughout the filling and packaging processes becomes essential, leading to higher operational costs. Consequently, facilities are investing in advanced fill-finish technologies to meet the growing need for safe and efficient production of these critical drugs. This investment is vital for maintaining the integrity of biologics while satisfying market demand, ultimately propelling the growth of the Fill Finish Manufacturing sector.

Restraints in the Fill Finish Manufacturing Market

The global fill finish manufacturing sector is facing a significant challenge due to a shortage of skilled professionals who are proficient in operating advanced manufacturing technologies and software. This lack of expertise hampers the effective adoption of automation and other technological innovations, particularly in regions where the pharmaceutical industry is still emerging. As a result, the growth and modernization of the fill finish manufacturing market are hindered, limiting its potential to improve efficiency and productivity. Addressing this skills gap is crucial to unlock the full benefits of technological advancements in the industry and facilitate its development.

Market Trends of the Fill Finish Manufacturing Market

The fill-finish manufacturing market is currently experiencing a significant surge driven by the rising demand for biologics and biosimilars. As pharmaceutical companies strive to deliver innovative therapies, there is a notable shift towards enhancing production capabilities. This trend is prompting manufacturers to invest in advanced technologies and streamlined processes aimed at improving production efficiency, ensuring product quality, and adhering to stringent regulatory standards associated with these complex biologics. Additionally, the proliferation of personalized medicine is further propelling the need for specialized fill-finish services, thus transforming the competitive landscape and driving growth within the industry by facilitating faster and more reliable product delivery to meet market demands.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Raw Material Analysis

Global Fill Finish Manufacturing Market Size by Product Type & CAGR (2025-2032)

Market Overview
Consumables
- Prefilled syringes
- Vials
- Glass Vials
- Plastic Vials
- Cartridges
- Ampoules
- Stoppers & Seals
- Vial Stoppers
- Aluminum Crimp Caps
- Plungers
- Needles
Equipment
- Filling Machines
- Closing/Sealing Machines
- Inspection Machines
- Lyophilizers
- Labeling Machines
- Capping Machines
- Integrated Systems

Global Fill Finish Manufacturing Market Size by Drug Type & CAGR (2025-2032)

Market Overview
Biologics
- Monoclonal Antibodies
- Vaccines
- Cell & Gene Therapies
- Recombinant Proteins
Small Molecules
Vaccines
Other Injectables

Global Fill Finish Manufacturing Market Size by End-user & CAGR (2025-2032)

Market Overview
Pharmaceutical Companies
Biopharmaceutical Companies
Contract Manufacturing Organizations (CMOs)

Global Fill Finish Manufacturing Market Size & CAGR (2025-2032)

North America (Product Type, Drug Type, End-user)
- US
- Canada
Europe (Product Type, Drug Type, End-user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Drug Type, End-user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Drug Type, End-user)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Drug Type, End-user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cytiva (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OPTIMA Packaging Group GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Curia Global, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aenova Group (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGD Pharma (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Groninger & Co. GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
West Pharmaceutical Services, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stevanato Group (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syntegon Technology GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Robert Bosch GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gerresheimer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Schott AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IMA Group (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AptarGroup, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vetter Pharma-Fertigung GmbH & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments